Key benefits of custom enzyme panels
- Faster identification of active enzymes
- Higher success rates due to targeted selection
- Early validation under real process conditions
- Reduced development time and cost
At BRAINBiocatalysts, enzyme candidates are selected using the MetXtra™ platform which integrates a large proprietary metagenomic database, public sequence databases, and AI-designed enzymes with a modular, customizable discovery pipeline to meet development targets.
Selected sequences are synthesized, expressed, and samples are delivered in a standardized plate format suitable for high-throughput assays.
